BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 24101602)

  • 1. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
    Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
    Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression of Quaking in Sporadic Alzheimer's Disease Patients is Both Upregulated and Related to Expression Levels of Genes Involved in Amyloid Plaque and Neurofibrillary Tangle Formation.
    Farnsworth B; Peuckert C; Zimmermann B; Jazin E; Kettunen P; Emilsson LS
    J Alzheimers Dis; 2016 May; 53(1):209-19. PubMed ID: 27163826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line.
    Sung HY; Choi EN; Ahn Jo S; Oh S; Ahn JH
    Biochem Biophys Res Commun; 2011 Nov; 414(4):700-5. PubMed ID: 22001921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease.
    Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT
    Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer's disease.
    Cong L; Jia J; Qin W; Ren Y; Sun Y
    Acta Neurol Belg; 2014 Sep; 114(3):195-206. PubMed ID: 24347181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
    PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PSEN1, p.E318G variant increases the risk of Alzheimer's disease in APOE-ε4 carriers.
    Benitez BA; Karch CM; Cai Y; Jin SC; Cooper B; Carrell D; Bertelsen S; Chibnik L; Schneider JA; Bennett DA; ; ; Fagan AM; Holtzman D; Morris JC; Goate AM; Cruchaga C
    PLoS Genet; 2013; 9(8):e1003685. PubMed ID: 23990795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease.
    Kwok JB; Loy CT; Hamilton G; Lau E; Hallupp M; Williams J; Owen MJ; Broe GA; Tang N; Lam L; Powell JF; Lovestone S; Schofield PR
    Ann Neurol; 2008 Oct; 64(4):446-54. PubMed ID: 18991351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
    Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
    Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling APOE ɛ3/4 allele-associated sporadic Alzheimer's disease in an induced neuron.
    Kim H; Yoo J; Shin J; Chang Y; Jung J; Jo DG; Kim J; Jang W; Lengner CJ; Kim BS; Kim J
    Brain; 2017 Aug; 140(8):2193-2209. PubMed ID: 28899010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer's disease patients.
    Sala Frigerio C; Lau P; Troakes C; Deramecourt V; Gele P; Van Loo P; Voet T; De Strooper B
    Alzheimers Dement; 2015 Nov; 11(11):1265-76. PubMed ID: 25937274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in Tau Pathology in P290S
    Huang M; Macdonald J; Lavenir I; Chen R; Craxton M; Slavik-Smith E; Davies SW; Goedert M
    eNeuro; 2022; 9(6):. PubMed ID: 36635241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of GSK3B and MAPT polymorphisms with Alzheimer's disease in Han Chinese.
    Zhang N; Yu JT; Yang Y; Yang J; Zhang W; Tan L
    Brain Res; 2011 May; 1391():147-53. PubMed ID: 21443865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
    van de Nes JA; Nafe R; Schlote W
    Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Late-Onset Sporadic Alzheimer's Disease through BMI1 Deficiency.
    Flamier A; El Hajjar J; Adjaye J; Fernandes KJ; Abdouh M; Bernier G
    Cell Rep; 2018 May; 23(9):2653-2666. PubMed ID: 29847796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of PSEN1 mutations on MAPT methylation in early-onset Alzheimer's disease.
    Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JB
    Curr Alzheimer Res; 2015; 12(8):745-51. PubMed ID: 26159201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.